As already discussed, B cells in the joints of patients with RA may directly participate to RANKL synthesis [33] and indirectly modulate the RANKL/osteoprotegerin (OPG) system through the production of proinflammatory cytokines, such as TNF and IL-17A [33, 39]. The gene discussed is IL17A; the disease is rheumatoid arthritis.